Director/PDMR shareholding

October 9, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") on 9 October 2018 that on the 5 and 8 October 2018 it purchased 54,000 and 460,899  Ordinary Shares of 1p, respectively, in the capital of the Company ("Ordinary Shares") at 3.60p per Ordinary Share (the “Purchase”).  Following the purchase, Vulpes has a total direct and indirect interest in 60,851,987 equivalent to 20.62% of Proteome Sciences' total issued share capital.

 

View PDF Version

« Back To News